David B. Feirstein, P.C.

David has advised clients on numerous significant matters, including the following: 

• EQT in its pending $8.8 billion joint venture with Blackstone Credit & Insurance

• Wyndham Hotels & Resorts in its successful defense of a $7.8 billion hostile takeover and full slate proxy contest by Choice Hotels International

• EQT in its $35 billion merger with Equitrans

• Vericast in the sale of its digital and print marketing businesses to R.R. Donnelley & Sons Company

• EQT in its $1.25 billion sale of non-operated natural gas assets in Northeast Pennsylvania to Equinor

• Sycamore Partners in its $1 billion acquisition of Chico’s FAS, Inc.

• Daseke, Inc. in its $1.1 billion acquisition by TFI International Inc.

• Rice Acquisition Corp. II in its $1.459 billion combination with NET Power

• Archaea Energy Inc. in its $4.1 billion sale to bp p.l.c.

• EQT in its $5.2 billion acquisition of Tug Hill’s upstream assets and XcL Midstream’s gathering and processing assets

• Celanese in its $11 billion acquisition of the majority of DuPont's Mobility & Materials Business

• Nautic Partners in its $570 million acquisition of Tabula Rasa HealthCare, Inc.

• Stone Point Capital in its acquisition of ECN Kessler Holdco 

• Special Committee of Board of Directors of Greenbacker Renewable Energy Company in its management internalization transaction 

• Stone Point Capital in its $2 billion acquisition of Tivity Health

• Vervent in its acquisition of First Equity Card Corporation 

• Novo Holdings in its acquisition of Medical Knowledge Group from Court Square Capital and Aisling Capital 

• Polestar Performance AB in its $20 billion combination with Gores Guggenheim Inc. 

• Home Point Capital in its $324 million sale to Mr. Cooper Group

• Nordic Capital-led consortium in its $7.3 billion acquisition of Inovalon

• Humana Inc. in its acquisition of EliteHealth Medical Practice and certain related businesses

• EQT Infrastructure in its $5.3 billion acquisition of Covanta Holding Corporation

• Bullish in its proposed $9 billion business combination with Far Peak Acquisition Corporation

• Celanese Corporation in its $1.15 billion acquisition of ExxonMobil’s Santoprene TPV elastomers business 

• Direct Selling Acquisition Corp. in its $223 million business combination with Hunch Mobility

• Rice Acquisition Corp., a special purpose acquisition company, in its $1.15 billion business combination with Aria Energy LLC and Archaea Energy LLC to form Archaea Energy, a publicly-traded renewable natural gas platform

• Stone Point Capital in its $6 billion acquisition of CoreLogic 

• Acadia Healthcare Company, Inc. in its £1.08 billion sale of The Priory Group to Waterland Private Equity

• Accenture in its acquisition of N3

• Radiology Partners in its $885 million acquisition of MEDNAX Radiology Solutions

• Accenture in the initial public offering of Duck Creek Technologies, Inc.

• Corning Inc. in Hemlock Semiconductor’s acquisition of the trichlorosilane business of DuPont, and concurrent acquisition by Corning of the remaining interest, which it did not already own, in Hemlock

• Accenture in its acquisition of CreativeDrive

• MultiPlan Inc. and its largest shareholder, Hellman & Friedman, in MultiPlan’s $11 billion combination with Churchill Capital Corp III

• Covetrus in its $250 million PIPE investment from Clayton, Dubilier & Rice

• HGGC in its $115 million strategic equity investment in Upland Software

• Infineon Technologies AG in its $10.1 billion acquisition of Cypress Semiconductor Corporation

• Cambrex Corporation in its $2.4 billion agreement to be acquired by Permira

• Colfax Corporation in its $1.8 billion sale of its Air and Gas Handling business to KPS Capital Partners

• Wyndham Worldwide in its approximately $1.3 billion sale of its European vacation rental business to Platinum Equity

• Wyndham Worldwide in its $1.95 billion acquisition of La Quinta Inns & Suites’ franchise and management businesses

• Wyndham Worldwide in its separation via spin-off into two separate publicly traded hospitality companies valued at approximately $11 billion, Wyndham Hotels & Resorts, Inc. and Wyndham Destinations, Inc.

• Marriott Vacations Worldwide in its $4.7 billion acquisition of Interval Leisure Group, Inc. (ILG)

• Varde Partners in its $1.4 billion acquisition of OneMain Financial

• Rice Energy in the successful defense against opposition by JANA Partners to the $6.7 billion acquisition by EQT

• Abbott Laboratories in its $5.3 billion acquisition of Alere

• Celanese Corporation in its proposed joint venture with Blackstone to create a global acetate tow supplier

• New Mountain Capital in its $596 million acquisition of TRC Companies, Inc.

• Fox Corporation in its $397 million acquisition of Credible Labs

• BETA Technologies in its raise of $318 million in Series C equity capital from a consortium led by QIA

• Micro Focus International plc in its $8.8 billion “Reverse Morris Trust” acquisition of Hewlett Packard Enterprise Company’s software business

• Celator Pharmaceuticals in its $1.5 billion sale to Jazz Pharmaceuticals

• Accenture in its joint venture with Apax Partners from the carve out of Accenture’s Duck Creek Technologies insurance claims, billing and policy administration software business

• Nexstar Broadcasting Group in connection with its $4.6 billion acquisition of Media General, ending a six-month public takeover battle during which Nexstar jumped Media General’s previously announced transaction with Meredith Corp.

• Accenture in its $830 million carve-out sale of Navitaire to Amadeus IT Holding SA

• IGATE Corporation in its $4 billion sale to Cap Gemini

• Burger King Worldwide Inc. in its $13.3 billion merger transaction with Tim Hortons Inc.

• Infineon Technologies AG in its $3 billion acquisition of International Rectifier Corporation

• Lazard as financial advisor to Reynolds American in its $27.4 billion acquisition of Lorillard

• Bristol-Myers Squibb in its $725 million (including milestone payments) acquisition of iPierian, a privately-held biotech company

• Beechcraft in its $1.4 billion sale of the company to Textron Inc.

• rue21, inc. in the $1.1 billion sale of the company to Apax Partners

• 3G Capital Partners Ltd. in its $28.0 billion acquisition, along with Berkshire Hathaway Inc., of H. J. Heinz Company

• Clearwire Corporation in Sprint’s acquisition of the stake in Clearwire which Sprint did not already own, implying a $14 billion enterprise value for Sprint and the unsolicited competing offer for Clearwire by DISH Networks

• Danaher Corporation in its $338 million acquisition of IRIS International, Inc.

• GeoEye in its merger with DigitalGlobe

• Bristol-Myers Squibb in its $7 billion acquisition of Amylin Pharmaceuticals and joint collaboration with AstraZeneca plc

• Burger King Worldwide Holdings, Inc. and its controlling stockholder, 3G Capital Partners Ltd., in connection with a business combination with Justice Holdings Ltd., a London Stock Exchange-listed public investment vehicle, resulting in a partial sale of Burger King to the Justice shareholders for $1.4 billion and a New York Stock Exchange listing of Burger King

• Bristol-Myers Squibb in its $2.5 billion acquisition of Inhibitex, Inc.

• Colgate-Palmolive Company in its €672 million acquisition of Sanex Brands from Unilever and related $210 million disposition of Colgate’s Colombian detergents business

• Mirant Corporation in its $3.1 billion merger of equals with RRI Energy, Inc.

• PVH in its $3 billion acquisition of Tommy Hilfiger

• MetLife in the recapitalization and split-off of its less than wholly owned subsidiary, RGA

• Apollo in its $16 billion buyout of Harrah’s with TPG

• Iscar in its $4 billion acquisition by Berkshire Hathaway

• ConocoPhillips in its multi-billion dollar oil sands joint venture with EnCana

• ConocoPhillips in its $35 billion acquisition of Burlington Resources

• EQT in its exchange agreement with Equinor USA Onshore Properties

• Altaris in its $540 million acquisition of Sharecare

• Altaris in its $316 million acquisition of Trean Insurance Group

• Altaris in its pending acquisition of Minaris Regenerative Medicine